RXFP1 and systemic sclerosis: In vitro studies of fibroblasts isolated from IPF and SSc lungs demonstrates minimal responsiveness to relaxin treatment in reducing extracellular matrix accumulation, but restoration of RXFP1 expression restores the anti-fibrotic effects in these cells [17].